Stock picks with research | support | resistance and technical analysis for trading | Day trading | stock investing in the market
day investing picks penny stock trading
Skip Navigation Links
    Home
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event
    Login


Join Now




stock Breakout for day trading

advertise 2 ۩  Daily market forecast
 
Stock : EBS |   Stock Recommendations : Buy
Sector : Biotech & Drugs |   First resistance : 18.19
Stock Name : EMERGENT BIOSOLUTIONS INC COM |   Second resistance :
Buy Near : |   Third resistance :
StopLoss : |   First Support : 16.11
Posted date : 11/2/2008 12:00:00 AM |   Second Support : 14.60


Emergent BioSolutions Inc. com (EBS) Stock has given a buy signal, with rising moving average. Stockhastic and ADX also given a buy signal.

   Emergent BioSolutions Inc. com (EBS) announced on 10/1/08, it will receive between $364 million and $404 million for new contracts to supply the U.S. government with anthrax vaccines. Emergent BioSolutions Inc. com (EBS) is a Biotechnology company. As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Emergent BioSolutions Inc. com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to Stock market and economic condition keep tight stop loss on all position. You can buy this Stock near $18



Portfolio stock



Recent News Head Lines
Promise Emerging for Emergent BioSolutions
(Tue, 22 Jun 2021 09:29:18 +0000)
Emergent BioSolutions (EBS) is a life sciences company with a focus on serving civilian and military clients by providing solutions for public health threats. The main value for EBS comes from its diversified product portfolio and pipeline, alongside its CDMO services that address public health threats. As a trusted partner to governments, NGOs, and major pharmaceutical and biotech innovators, it commands a leadership position in key public health threat markets. The company operates four busine
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - EBS
(Mon, 21 Jun 2021 21:01:00 +0000)
New York, New York--(Newsfile Corp. - June 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emergent Biosolutions Inc. ("Emergent Bio") (NYSE: EBS) between April 24, 2020 and April 16, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Maryland. To get ...
Today - Final Deadline for Investors with Losses Exceeding $250K to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC
(Mon, 21 Jun 2021 19:30:00 +0000)
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ('Emergent' or 'the Company') (NYSE:EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021,both dates inclusive (the 'Class Period').
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EBS, ATER and WISH
(Mon, 21 Jun 2021 18:00:00 +0000)
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
MONDAY DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
(Mon, 21 Jun 2021 17:20:00 +0000)
LOS ANGELES, CA / ACCESSWIRE / June 21, 2021 /The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. ('Emergent BioSolutions' or 'the Company') (NYSE:EBS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.


Never go against major trend for day trading | stock trading
  


Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Portfolio stock - EMERGENT BIOSOLUTIONS INC COM for Stock investing stock trading day trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.